Here are today's top news headlines from�Fool.com. Check back throughout the day as this list is updated, and follow us on Twitter at�TMFBreaking.
Stillwater CEO to Step Down
Consumer Credit Oozes Up 0.4%
Sagent Recalls Anesthesia Drug Dosages
Salesforce Hires a President
Integrys Applies for 6% Natural Gas Rate Increase
FedEx Increasing Freight Shipping Rates by 4.5%
iRobot, Cisco Team to Develop Video-Conferencing Robot
ECB Defends Bond Program Before German Hearing
AT&T Increases Wait for Subsidized-Phone Upgrade Eligibility
Dollar Tree Names New President
Duke Energy's New Indiana Coal Facility Begins Operation
Elan Rejects Latest Royalty Pharma Offer
McDonald's May Comps Rise 2.6%
AstraZeneca to Acquire Pearl Therapeutics for Up to $1.15 Billion
Sprint to Launch Its Own Smartphone
Canadian Solar Lands $301 Million Contract to Help Build Solar Power Plant
Best Forestry Stocks To Own For 2015: Abbott Laboratories(ABT)
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. The company offers adult and pediatric pharmaceuticals for rheumatoid and psoriatic arthritis, ankylosing spondylitis, psoriasis, and Crohn's disease; dyslipidemia; HIV infection; prostate cancer, endometriosis and central precocious puberty, and anemia caused by uterine fibroids; respiratory syncytial virus; adult males who have low or no testosterone; secondary hyperparathyroidism; hypothyroidism; and pancreatic exocrine insufficiency, as well as anesthesia products. It also provides diagnostic products, such as immunoassay systems; chemistry systems; assays used for screening and/or diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, physiological, and infectious diseases; instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infections agents; genomic-b ased tests; hematology systems and reagents; and point-of-care diagnostic systems and tests for blood analysis. In addition, the company offers a line of pediatric and adult nutritional products. Further, it provides coronary, endovascular, vessel closure, and structural heart devices, such as drug-eluting stent systems, coronary metallic stents, balloon dilatation products, coronary guidewires, vessel closure devices, carotid stent systems, percutaneous valve repair systems, and drug eluting bioresorbable vascular products. Additionally, the company provides blood glucose monitoring meters, test strips, data management software, and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, lasik surgery, contact lens, and dry eye products, as well as branded generic pharmaceutical products. Abbott primarily serves retailers, wholesalers, hospitals, and health care facilities. Abbott was founded in 1888 and is headquartered in Abbott Park, Illinois.
Advisors' Opinion:- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, health care giant Abbott Laboratories (NYSE: ABT ) has earned a coveted five-star ranking.
- [By Marc Bastow]
Healthcare products and pharmaceuticals manufacturer Abbott Laboratories (ABT) raised its quarterly dividend 57% to 22 cents per share, payable Feb. 15, 2014, to shareholders of record as of Jan. 15. This is the 42nd consecutive annual increase in ABT’s dividend.
ABT Dividend Yield: 2.37% - [By Philip Springer]
This was a big week for the global pharmaceutical industry. First, rumors of one deal suggested a possible return to the industry’s old self-destructive ways. But then two other transactions were announced that signaled continuation of a newer trend that’s much healthier for shareholders.
On Monday, it was reported that New York-based Pfizer Inc. (NYSE: PFE) had been in talks to acquire AstraZeneca PLC (NYSE: AZN), headquartered in London, for over $100 billion. The companies apparently broke off the discussions.
If such a transaction were to occur, it would be the latest in a long series of megamergers that characterized the corporate strategies of Pfizer, Swiss drug giant Novartis AG (NYSE: NVS) and others in the 1990s and 2000s. Back then, the aim was to acquire rivals in multibillion-dollar deals that broadened the buyers’ businesses to cover more diseases and new health-care areas.
The catalyst for this buying binge was the so-called patent cliff, in which some of the sector’s biggest drugs faced the loss of patents that protected them from competition, resulting in reduced revenues and earnings.
Since then, however, the patent cliff problem has waned because many of those patent expirations have already occurred. And the bigger, combined companies generally have come up short on development of new blockbuster drugs. Also, excessive diversification has brought weak competitive positions in some niches.
But the current industry trend is for companies to focus more on their core strengths instead of diversifying. Pfizer, Bristol-Myers Squibb (NYSE: BMY), Johnson & Johnson (NYSE: JNJ) and Abbott Laboratories (NYSE: ABT) have made such moves over the last few years in order to focus on what they consider higher-growth prospects.
Tuesday brought more of the same. Novartis and UK-based GlaxoSmithKline (NYSE: GSK) announced more than $20 billion in deals. Novartis is to sell its animal-drugs busi - [By Dan Carroll and Max Macaluso, Ph.D.]
We're into the heart of earnings season, and several of the medical device industry's biggest players have already reported quarterly results. Johnson & Johnson (NYSE: JNJ ) led off among the biggest players, with fellow diversified health care firm Abbott Labs (NYSE: ABT ) and more concentrated company St. Jude Medical (NYSE: STJ ) following suit last week.
10 Best Canadian Stocks To Invest In 2014: TotalFinaElf S.A.(TOT)
TOTAL S.A., together with its subsidiaries, operates as an integrated oil and gas company worldwide. The company operates through three segments: Upstream, Downstream, and Chemicals. The Upstream segment engages in the exploration, development, and production of oil and natural gas. It also involves in the transportation, trade, and marketing of natural gas and liquefied natural gas (LNG), as well as in LNG re-gasification and natural gas storage operations. In addition, this segment engages in the shipping and trade of liquefied petroleum gas (LPG); power generation from gas-fired power plants, nuclear, or renewable energies; production, trade, and marketing of coal, as well as in solar power systems and technology operations. As of December 31, 2010, it had combined proved reserves of 10,695 Mboe of oil and gas. The Downstream segment involves in refining, marketing, trading, and shipping crude oil and petroleum products. It also produces a range of specialty products, s uch as lubricants, LPG, jet fuel, special fluids, bitumen, marine fuels, and petrochemical feedstock. This segment holds interests in 24 refineries located in Europe, the United States, the French West Indies, Africa, and China, as well as operates a network of 17,490 service stations. The Chemicals segment produces base chemicals, including petrochemicals and fertilizers, as well as engages in rubber processing, resins, adhesives, and electroplating activities. TOTAL S.A. was founded in 1924 and is based in Paris, France.
Advisors' Opinion:- [By Sara Sjolin]
Among notable movers in the pan-European index, shares of Total SA (FR:FP) � (TOT) �climbed 3.1% after Barclays lifted the oil giant to equal weight from underweight. The analysts said that the company�� capital markets day was ��nough to convince us that it can control capex more than we had previously anticipated.��
- [By Arjun Sreekumar]
For instance, Total SA (NYSE: TOT ) recently threw in the towel on its Voyageur�Upgrader project, a 200,000-barrels-a-day facility that was designed to "upgrade" bitumen into crude oil. It sold its 49% stake in Voyageur to its joint venture partner, Suncor Energy (NYSE: SU ) , for $500 million, arguing that the project was "no longer justified from a strategic and economic" standpoint. Not long after, Suncor also decided to abandon the project, for which it took a C$1.5 billion write-down.
- [By Maxx Chatsko]
Lesson learned
The financial situation at Amyris is less than enviable. Whereas fellow industrial biotech company Solazyme has hit every major milestone and had no problem raising funds, Amyris has had to take the more dilutive route for shareholders. Still, large commercial partners Total (NYSE: TOT ) and Cosan (NYSE: CZZ ) haven't backed down in their support of the company. Total upped its investment in Amyris during several rough patches in the past year after incurring significant paper losses on the roughly 20% stake in the company. Total even has its own webpage for the partnership, which speaks to its long-term vision for Amyris' platform, especially in renewable diesel. - [By Sara Murphy]
HSBC recently conducted an analysis that looked at European oil majors' at-risk carbon reserves. The study found Norway's�Statoil (NYSE: STO ) �to be the worst affected, with approximately 17% of its market capitalization at risk. HSBC also calculated that 6% of�BP's� (NYSE: BP ) reserves are at risk, along with 5% of�Total's (NYSE: TOT ) and 2% of�Shell's� (NYSE: RDS-A ) .�
10 Best Canadian Stocks To Invest In 2014: Hudbay Minerals Inc (HBM)
HudBay Minerals Inc., an integrated mining company, engages in the exploration and development of copper, zinc, and precious metals mines in North and South America. It primarily produces copper concentrates containing copper, gold, and silver; and zinc metal. The company principally owns underground 777 mine that covers an area of 4,400 hectares and is located in Flin Flon, Manitoba. It also owns ore concentrators and a zinc production facility in northern Manitoba and Saskatchewan. The company was founded in 1992 and is based in Toronto, Canada.
Advisors' Opinion:- [By Dan Caplinger]
Dan also highlights a new agreement with Brazil's Vale (NYSE: VALE ) as an example of a new partner streaming agreement that features a focus on gold. Can Silver Wheaton continue to profit from future agreements with partners such as Barrick Gold (NYSE: ABX ) , Primaro Mining (NYSE: PPP ) , and Hudbay Minerals (NYSE: HBM ) ?
- [By Sean Williams]
In August, Silver Wheaton reached its most recent deal with HudBay Minerals (NYSE: HBM ) , securing the rights to its silver production at a low fixed-cost of $5.90 per ounce and 100% of its gold production at its 777 mine through at least 2016 for $400 an ounce In return, Silver Wheaton will fork over up to $750 million in cash for the buildout of HudBay's Constancia mine. Even with the tumble metal prices took this week, Silver Wheaton's margins will continue to remain fat with gold hovering near $1,400 an ounce and silver near $23 an ounce, and its dividend could still head even higher.
10 Best Canadian Stocks To Invest In 2014: Genpact Limited (G)
Genpact Limited provides business process management and information technology services worldwide. It offers finance and accounting services, including accounts payable services, payment and inquiry management, order to cash services, preparation of financial statements, closing and reporting, cash management, treasury, cash flow analysis, tax return preparation, financial planning and analysis, governance, and internal controls services. The company also provides smart decision services, such analytics and research; business consulting and enterprise risk consulting services comprising internal audit, compliance advisory, regulatory advisory, enterprise, IT, and fraud risk management services; and re-engineering services. In addition, it offers supply chain and procurement services consisting of direct and indirect sourcing and procurement, demand forecasting and management, engineering, inventory optimization and planning, fleet and logistics, and aftermarket services. Further, the company provides enterprise application services comprising enterprise resource planning, supply chain management, financial management and customer relationship management solutions, and securities trading and accounting services, as well as testing, database administration, and architecture services; IT management services, including onsite and remote monitoring, management and support of the IT functions, and IT infrastructures; and collections and customer services in the areas of consumer finance, commercial finance, and mortgage services. It primarily serves banking and insurance, capital markets, consumer goods and retail, life sciences, infrastructure, manufacturing and services, and healthcare industries. Genpact Limited has a strategic partnership with Research Now. The company was founded in 1997 and is based in Hamilton, Bermuda.
Advisors' Opinion:- [By Jake L'Ecuyer]
Equities Trading DOWN
Shares of Genpact (NYSE: G) were down 17.82 percent to $14.16 after the company issued a downbeat FY14 revenue forecast.
10 Best Canadian Stocks To Invest In 2014: China Metro-Rural Holdings Limited(CNR)
China Metro-Rural Holdings Limited, through its subsidiaries, primarily engages in the development and operation of agricultural logistics and trade centers in northeast China. It also involves in purchasing, processing, assembling, merchandising, and distributing pearls and jewelry products. The company markets its pearls and jewelry products to wholesale distributors and mass merchandisers in Europe, the United States, Hong Kong, and other parts of Asia. In addition, it develops, sells, and leases residential and commercial properties in Hong Kong and the People?s Republic of China. The company is based in Tsimshatsui, Hong Kong.
Advisors' Opinion:- [By Katie Brennan]
Canadian National Railway Co. (CNR) added 0.9 percent to C$104.93 and Canadian Pacific Railway Ltd. rose 1.7 percent to C$131.73.
Niko Resources surged 3.4 percent to $8.64 after the company entered an agreement for a $60 million loan that will be funded by a group of institutional investors. Net proceeds from the loan will be used to fund working capital requirements.
10 Best Canadian Stocks To Invest In 2014: Franklin Covey Company (FC)
Franklin Covey Co. provides training and consulting solutions to address leadership, execution, productivity, trust, customer loyalty, sales performance, and education problems worldwide. The company also offers clients with training in management skills, relationship skills, and individual effectiveness, as well as personal-effectiveness literature and electronic educational solutions. In addition, it sells a suite of individual-effectiveness and leadership-development training products; and books, e-books, audio media, downloadable and paper-based tools, content-rich software applications for smart phones and other handheld devices, training accessories, and other related products. The company delivers its products and services through onsite presentations, facilitators, international licensees, e-learning, public workshops, custom solutions, intellectual property licenses, and media publishing methods to organizational clients, including corporations, governmental agenc ies, educational institutions, and other organizations, as well as individual clients. Franklin Covey Co. was founded in 1983 and is headquartered in Salt Lake City, Utah.
Advisors' Opinion:- [By Laura Brodbeck]
Tuesday
Earnings Expected: A. Schulman (NASDAQ: SHLM), Acuity Brands (NYSE: AYI), Franklin Covey (NYSE: FC) and Paychex (NASDAQ: PAYX) Economic Releases Expected: US ISM manufacturing PMI, US redbook, British manufacturing PMI, German unemployment rate, French manufacturing PMI, Italian manufacturing PMI, Spanish manufacturing PMI and Reserve Bank of Australia interest rate decisionWednesday
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Franklin Covey (NYSE: FC ) , whose recent revenue and earnings are plotted below. - [By Seth Jayson]
Franklin Covey (NYSE: FC ) reported earnings on July 9. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended June 1 (Q3), Franklin Covey beat expectations on revenues and beat expectations on earnings per share. - [By Laura Brodbeck]
Tuesday
Earnings Expected: IHS Inc. (NYSE: IHS), Commercial Metals Company (NYSE: CMC), Franklin Covey Company (NYSE: FC), Micron Technology, Inc. (NASDAQ: MU), Apollo Group, Inc. (NASDAQ: APOL) Economic Releases Expected: French consumer confidence, German unemployment rate, Brazilian CPI, Canadian trade balanceWednesday
10 Best Canadian Stocks To Invest In 2014: Kinross Gold Corporation(KGC)
Kinross Gold Corporation, together with its subsidiaries, engages in mining and processing gold ores. It also involves in the exploration and acquisition of gold bearing properties. The company?s gold production and exploration activities are carried out principally in the Americas, Africa, and the Russian Federation. As of December 31, 2010, its proven and probable mineral reserves were 62.4 million ounces of gold, 90.9 million ounces of silver, and 1.4 billion pounds of copper. The company was founded in 1972 and is based in Toronto, Canada.
Advisors' Opinion:- [By Hebba Investments]
Even with rising Q2 costs, GG still has lower true all-in costs than many of its larger competitors' Q1FY13 costs. Compared to Q1FY13 numbers of competitors such as Yamana Gold (AUY) (costs just over $1300), Kinross Gold (KGC) (costs above $1350), Silvercrest Mines (SVLC) (costs below $1100), Newmont Gold (NEM) (costs around $1300) Agnico-Eagle (AEM) (costs around $1400) and Barrick Gold (ABX) (costs around $1200).
- [By Rich Smith]
Today's high cash-cost of digging through 9.4 tons of dirt in hopes of extracting a golf-ball's weight of pure gold explains why most of the major gold miners -- from low-cost producer Barrick, all the way up through Kinross (NYSE: KGC ) , Newmont (NYSE: NEM ) and Goldcorp (NYSE: GG ) -- are currently in a negative free cash flow state. (Well, the high cost plus the relatively lower prices that miners are getting for their gold today).
- [By Rich Duprey]
Of course, not all of Barrick's problems are of its own making. Other major miners, such as Vale� (NYSE: VALE ) , Rio Tinto (NYSE: RIO ) , and BHP Billiton, are selling mines or considering doing so to shore up finances and concentrate on core operations. And gold has been in a rut that's caused some of the best miners from�Yamana Gold (NYSE: AUY ) to Kinross Gold (NYSE: KGC ) to lose 25% or more of their value in the past month. A week ago, gold suffered its largest one-day drop in three decades.
- [By Jim Jubak]
At $1300 an ounce, Goldcorp's assumed price of gold is still significantly above the $1140 at Barrick Gold (ABX) or the $1,200 an ounce at Kinross Gold (KGC). I expect that Yamana Gold AUY, set to report on February 18, which already used a price assumption below $1300 an ounce, will reduce its price assumption even further. That leaves plenty of room for another reduction in reserves at Goldcorp on a lower assumed price. Gold closed at $1273 an ounce on average in the fourth quarter of 2013, 4% lower than in the third quarter and 26% less than in the fourth quarter of 2012.
No comments:
Post a Comment